ENCODE biosample ENCBS238XWI

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission package

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ATXN2L

text: child

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS238XWI: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ATXN2L. (ATXN2L-BGHcLV29-12B)


ENCODE biosample ENCBS238ZBD

status: PUBLIC

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: 35 year

tag: attribute

characteristic: age

text: activated CD4-positive, alpha-beta T cell

characteristic: cell type

text: Homo sapiens male adult (35 years) activated CD4-positive, alpha-beta T primary cell treated with 10 ng/mL Interleukin-2 for 14 days, anti-CD3 and anti-CD28 coated beads for 24 hours, anti-CD3 and anti-CD28 coated beads for 14 days

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: Yijun Ruan, JAX

text: Homo sapiens

characteristic: organism

text: primary cell

characteristic: sample type

text: male

characteristic: sex

text: AllCells

characteristic: source

text: ENCODE biosample ENCBS238ZBD

characteristic: title

text: treatment_term_id: UniProtKB:P60568; treatment_term_name: Interleukin-2; treatment_type: protein; duration: 14; duration_units: day; treatment_term_name: anti-CD3 and anti-CD28 coated beads; treatment_type: antibody; duration: 24; duration_units: hour; treatment_term_name: anti-CD3 and anti-CD28 coated beads; treatment_type: antibody; duration: 14; duration_units: day;

characteristic: treatments


ENCODE biosample ENCBS242UJR

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

text: 35 year

text: adult

text: Yijun Ruan, JAX

characteristic: lab

text: Homo sapiens

text: primary cell

text: male

text: AllCells

text: ENCODE biosample ENCBS242UJR


ENCODE biosample ENCBS242ZXS

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: 58 year

characteristic: cell line

text: Homo sapiens A549 cell line treated with 1 uM DMSO (agonist) for 4 hours

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS242ZXS

text: treatment_term_id: CHEBI:28262; treatment_term_name: DMSO; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS248EXP

text: ENCODE

text: live

text: Generic

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SMG9

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS248EXP: RNA-seq on K562 cells treated with a CRISPR gRNA against SMG7. (SMG7-BGKcLV33-58)


ENCODE biosample ENCBS248VGN

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: 58 year

text: Homo sapiens A549 cell line treated with 1 uM ZK216348 (agonist) for 4 hours

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS248VGN

characteristic: title

text: treatment_term_name: ZK216348; treatment_type: chemical; duration: 4; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS249NVQ

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CHCHD3

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS249NVQ: RNA-seq on K562 cells treated with a CRISPR gRNA against CHCHD3. (CHCHD3-BGKcLV28-18)


ENCODE biosample ENCBS252NUU

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: 53 year

characteristic: age

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ATXN2L

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS252NUU: RNA-seq on K562 cells treated with a CRISPR gRNA against ATXN2L. (ATXN2L-BGKcLV26-39)


ENCODE biosample ENCBS252YBV

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: 49 year

text: motor neuron

characteristic: cell type

text: Homo sapiens male adult (49 years) motor neuron in vitro differentiated cells, preserved by flash-freezing

text: adult

characteristic: dev stage

characteristic: donor ID

text: Donor with Amyotrophic Lateral Sclerosis

characteristic: health state

text: Michael Snyder, Stanford

text: Homo sapiens

characteristic: organism

text: in vitro differentiated cells

characteristic: sample type

text: male

text: Cooper-Knock lab, University of Sheffield, UK

text: ENCODE biosample ENCBS252YBV: RNA-seq on human


ENCODE biosample ENCBS253LWF

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 90 or above year

text: Homo sapiens female adult (90 or above years) middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

characteristic: sex

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS253LWF: human_brain_Rush ID_9867116_BS108_ENC4_cDNA662

characteristic: title


ENCODE biosample ENCBS253TGN

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CPSF2

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS253TGN: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CPSF2. (CPSF2-BGHcLV29-34)


ENCODE biosample ENCBS255XED

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RIOK2

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS255XED: RNA-seq on K562 cells treated with a CRISPR gRNA against RIOK2. (RIOK2-BGKcLV30-36)


ENCODE biosample ENCBS257FNC

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 21 year

text: activated T-cell

characteristic: cell type

text: Homo sapiens female adult (21 years) activated T-cell primary cell treated with 50 U/mL Interleukin-2 for 72 hours, anti-CD3 and anti-CD28 coated beads for 72 hours

text: adult

text: John Stamatoyannopoulos, UW

text: Homo sapiens

characteristic: organism

text: primary cell

characteristic: sample type

text: female

characteristic: sex

text: StemExpress

text: ENCODE biosample ENCBS257FNC

text: treatment_term_id: UniProtKB:P60568; treatment_term_name: Interleukin-2; treatment_type: protein; duration: 72; duration_units: hour; treatment_term_name: anti-CD3 and anti-CD28 coated beads; treatment_type: antibody; duration: 72; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS257FWX

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens RAD21 treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

characteristic: source

text: ENCODE biosample ENCBS257FWX

characteristic: title

text: treatment_term_name: 5-Phenyl-1H-indole-3-acetic acid; treatment_type: chemical; duration: 6; duration_units: hour;


ENCODE biosample ENCBS258NMY

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: 53 year

characteristic: age

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SECISBP2

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS258NMY: RNA-seq on K562 cells treated with a CRISPR gRNA against SEC31A. (SEC31A-BGKcLV33-38)


ENCODE biosample ENCBS262WNW

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 53 year

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS262WNW: RNA-seq on K562 cells treated with a CRISPR gRNA against RIOK2. (RIOK2-BGKcLV30-35)


ENCODE biosample ENCBS264KRF

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens MED14

text: adult

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS264KRF


ENCODE biosample ENCBS265LMY

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: SRA accession

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ARHGEF2

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS265LMY: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ARHGEF2. (ARHGEF2-BGHcLV29-4)

characteristic: title


ENCODE biosample ENCBS266RDY

text: ENCODE

text: live

text: Generic

text: endothelial cell of umbilical vein

characteristic: cell type

text: Homo sapiens male newborn endothelial of umbilical vein primary cell treated with 500 rad irradiation

characteristic: description

text: newborn

characteristic: dev stage

characteristic: donor ID

text: Mats Ljungman, UMichigan

characteristic: lab

text: Homo sapiens

text: primary cell

text: male

text: Lonza

text: ENCODE biosample ENCBS266RDY

text: treatment_term_name: irradiation; treatment_type: irradiation;

characteristic: treatments


ENCODE biosample ENCBS266VSE

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ATP5F1A

text: child

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

text: ATCC

text: ENCODE biosample ENCBS266VSE: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ATP5A1. (ATP5A1-BGHcLV29-10)


ENCODE biosample ENCBS267ADR

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line treated with 100 nM GSK J4 for 48 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS267ADR: RNA-seq on human cell line K562

text: treatment_term_name: GSK J4; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS270HKL

text: ENCODE

text: live

text: Generic

text: 15 year

characteristic: age

text: Homo sapiens A673 cell line treated with 500 rad irradiation

characteristic: description

text: child

characteristic: dev stage

characteristic: donor ID

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS270HKL

characteristic: title


ENCODE biosample ENCBS270XPA

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 30 year

characteristic: cell line

text: Homo sapiens WTC11 cell line treated with 7.5 uM CHIR 99021 for 48 hours, 2 days post differentiation, preserved by flash-freezing

text: adult

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: Coriell

text: ENCODE biosample ENCBS270XPA: iPSC differentiation in to cardiomycytes

text: treatment_term_id: CHEBI:91091; treatment_term_name: CHIR 99021; treatment_type: chemical; duration: 48; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS271JMP

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 53 year

text: Homo sapiens K562 cell line treated with 25 uM Galeterone for 24 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS271JMP: RNA-seq on human cell line K562

text: treatment_term_name: Galeterone; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS273CKO

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ADK

characteristic: description

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS273CKO: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ADK. (ADK-BGHcLV25-15)


ENCODE biosample ENCBS273QOE

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line treated with 10 uM AR-42 for 4 hours, preserved by flash-freezing

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS273QOE: RNA-seq on human cell line K562

characteristic: title

text: treatment_term_name: AR-42; treatment_type: chemical; duration: 4; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS275EQQ

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 84 year

text: Homo sapiens male adult (84 years) with Cognitive impairment, Alzheimer's disease; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

characteristic: lab

text: Homo sapiens

text: tissue

text: male

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS275EQQ: human_brain_Rush ID_E7286104_BS208_ENC4_cDNA763


ENCODE biosample ENCBS275ZVJ

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 48 year

characteristic: cell line

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens POLR2A treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS275ZVJ

text: treatment_term_name: 5-Phenyl-1H-indole-3-acetic acid; treatment_type: chemical; duration: 6; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS277ZLX

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens DCPS

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS277ZLX: RNA-seq on K562 cells treated with a CRISPR gRNA against DCPS. (DCPS-BGKcLV28-63)


ENCODE biosample ENCBS278BDZ

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens CDK7

text: adult

characteristic: dev stage

characteristic: donor ID

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

characteristic: source

text: ENCODE biosample ENCBS278BDZ

characteristic: title


ENCODE biosample ENCBS278BSR

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 58 year

characteristic: cell line

text: Homo sapiens A549 cell line treated with 1 uM GW870086 (agonist) for 4 hours

text: adult

text: Tim Reddy, Duke

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS278BSR

text: treatment_term_name: GW870086; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS279YBS

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SAMHD1

text: child

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: ATCC

text: ENCODE biosample ENCBS279YBS: RNA-seq on HepG2 cells treated with a CRISPR gRNA against SAMHD1. (SAMHD1-BGHcLV31-23)


ENCODE biosample ENCBS282XIF

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens DDX18

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS282XIF: RNA-seq on K562 cells treated with a CRISPR gRNA against DDX18. (DDX18-BGKcLV28-71)


ENCODE biosample ENCBS283KBT

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line treated with 1% DMSO for 48 hours, preserved by flash-freezing

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS283KBT: RNA-seq on human cell line K562

text: treatment_term_name: DMSO; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS283NSB

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SPATS2

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS283NSB: RNA-seq on K562 cells treated with a CRISPR gRNA against SNW1. (SNW1-BGKcLV33-66)

characteristic: title


ENCODE biosample ENCBS286GJK

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

text: 48 year

text: adult

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS286GJK


ENCODE biosample ENCBS286JRV

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: SRA accession

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CLNS1A

characteristic: description

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS286JRV: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CLNS1A. (CLNS1A-BGHcLV29-22)


ENCODE biosample ENCBS287UQB

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SNUPN

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS287UQB: RNA-seq on K562 cells treated with a CRISPR gRNA against SMG8. (SMG8-BGKcLV33-59)


ENCODE biosample ENCBS287YSQ

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 5 uM JQ1 for 12 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS287YSQ: RNA-seq on human cell line K562

characteristic: title

text: treatment_term_name: JQ1; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS288BQH

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission package

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens SMARCA5 treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS288BQH

text: treatment_term_name: 5-Phenyl-1H-indole-3-acetic acid; treatment_type: chemical; duration: 6; duration_units: hour;


ENCODE biosample ENCBS289SBJ

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line treated with 10 nM Bortezomib for 4 hours, preserved by flash-freezing

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS289SBJ: RNA-seq on human cell line K562

text: treatment_term_name: Bortezomib; treatment_type: chemical; duration: 4; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS291NHT

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 5 uM JQ1 for 4 hours, preserved by flash-freezing

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS291NHT: RNA-seq on human cell line K562

text: treatment_term_name: JQ1; treatment_type: chemical; duration: 4; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS296FKB

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: 36 year

text: MCF 10A

text: Homo sapiens MCF 10A cell line

text: adult

text: fibrocystic disease

text: Mats Ljungman, UMichigan

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS296FKB

characteristic: title


ENCODE biosample ENCBS297KSK

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line treated with 7.5 nM Vorinostat for 24 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS297KSK: RNA-seq on human cell line K562

text: treatment_term_name: Vorinostat; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS297YGW

characteristic: External Id

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens BARD1

characteristic: description

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS297YGW: RNA-seq on HepG2 cells treated with a CRISPR gRNA against BARD1. (BARD1-BGHcLV25-27)


ENCODE biosample ENCBS298JFY

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission model

text: 58 year

characteristic: cell line

text: Homo sapiens A549 cell line treated with 1 uM CpdA (agonist) for 4 hours

text: adult

characteristic: dev stage

characteristic: donor ID

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS298JFY

text: treatment_term_name: CpdA; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS298SZT

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ADAT1

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS298SZT: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ADAT1. (ADAT1-BGHcLV25-12)

characteristic: title


ENCODE biosample ENCBS301QVL

characteristic: External Id

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with mild cognitive impairment; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS301QVL: human_brain_Rush ID_E3616882_BS195_ENC4_cDNA750


ENCODE biosample ENCBS304EXR

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: SRA accession

text: 58 year

characteristic: age

text: Homo sapiens A549 cell line treated with 1 uM AZD9567 (agonist) for 4 hours

characteristic: description

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS304EXR

text: treatment_term_name: AZD9567; treatment_type: chemical; duration: 4; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS304KCD

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission model

text: 50 year

text: activated T-helper 17 cell

characteristic: cell type

text: Homo sapiens male adult (50 years) activated T-helper 17 primary cell treated with 50 U/mL Interleukin-2 for 72 hours, anti-CD3 and anti-CD28 coated beads for 72 hours

text: adult

characteristic: dev stage

characteristic: donor ID

text: John Stamatoyannopoulos, UW

text: Homo sapiens

text: primary cell

text: male

text: StemExpress

characteristic: source

text: ENCODE biosample ENCBS304KCD

text: treatment_term_id: UniProtKB:P60568; treatment_term_name: Interleukin-2; treatment_type: protein; duration: 72; duration_units: hour; treatment_term_name: anti-CD3 and anti-CD28 coated beads; treatment_type: antibody; duration: 72; duration_units: hour;


ENCODE biosample ENCBS304XWN

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 48 year

characteristic: cell line

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens CTCF treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS304XWN

characteristic: title

text: treatment_term_name: 5-Phenyl-1H-indole-3-acetic acid; treatment_type: chemical; duration: 6; duration_units: hour;


ENCODE biosample ENCBS305EMK

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 90 or above year

characteristic: age

text: Homo sapiens female adult (90 or above years) with Alzheimer's disease; middle frontal area 46 tissue

characteristic: description

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS305EMK: human_brain_Rush ID_E2962456_BS145_ENC4_cDNA695


ENCODE biosample ENCBS305UQQ

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission model

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with Cognitive impairment, Alzheimer's disease; middle frontal area 46 tissue

text: adult

characteristic: dev stage

characteristic: donor ID

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

characteristic: sex

text: Rush University

characteristic: source

text: middle frontal area 46

text: ENCODE biosample ENCBS305UQQ: human_brain_Rush ID_E5108249_BS182_ENC4_cDNA736


ENCODE biosample ENCBS308GNV

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 1% DMSO for 12 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS308GNV: RNA-seq on human cell line K562

text: treatment_term_name: DMSO; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS308QTA

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 90 or above year

characteristic: age

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

text: female

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS308QTA: human_brain_Rush ID_E2987977_BS146_ENC4_cDNA696

characteristic: title


ENCODE biosample ENCBS309JWT

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission model

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens MED14 treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS309JWT


ENCODE biosample ENCBS309SJI

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 35 year

text: activated T-helper 2 cell

characteristic: cell type

text: Homo sapiens male adult (35 years) activated T-helper 2 primary cell treated with 5 ug/mL Interferon-gamma antibody for 36 hours, anti-CD3 and anti-CD28 coated beads for 24 hours, 10 ng/mL Interleukin-2 for 14 days, anti-CD3 and anti-CD28 coated beads for 14 days, 100 ng/mL Interleukin-4 for 36 hours

text: adult

text: Yijun Ruan, JAX

text: Homo sapiens

text: primary cell

text: male

characteristic: sex

text: AllCells

characteristic: source

text: ENCODE biosample ENCBS309SJI

text: treatment_term_name: Interferon-gamma antibody; treatment_type: antibody; duration: 36; duration_units: hour; treatment_term_name: anti-CD3 and anti-CD28 coated beads; treatment_type: antibody; duration: 24; duration_units: hour; treatment_term_id: UniProtKB:P60568; treatment_term_name: Interleukin-2; treatment_type: protein; duration: 14; duration_units: day; treatment_term_name: anti-CD3 and anti-CD28 coated beads; treatment_type: antibody; duration: 14; duration_units: day; treatment_term_id: UniProtKB:P05112; treatment_term_name: Interleukin-4; treatment_type: protein; duration: 36; duration_units: hour;


ENCODE biosample ENCBS310NAE

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

text: 71 year

text: Homo sapiens male adult (71 years) middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

characteristic: lab

text: Homo sapiens

text: tissue

text: male

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS310NAE: human_brain_Rush ID_9158123_BS107_ENC4_cDNA661


ENCODE biosample ENCBS311LDY

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: SRA accession

text: 47 year

characteristic: age

text: natural killer cell

text: Homo sapiens male adult (47 years) natural killer primary cell treated with 100 ng/mL Interleukin-12 subunit alpha for 72 hours, 100 ng/mL Interleukin-15 for 72 hours, 100 ng/mL Interleukin-12 subunit beta for 72 hours, 100 ng/mL Interleukin-18 for 72 hours

text: adult

text: John Stamatoyannopoulos, UW

text: Homo sapiens

characteristic: organism

text: primary cell

text: male

text: StemExpress

text: ENCODE biosample ENCBS311LDY

characteristic: title

text: treatment_term_id: UniProtKB:P29459; treatment_term_name: Interleukin-12 subunit alpha; treatment_type: protein; duration: 72; duration_units: hour; treatment_term_id: UniProtKB:P40933; treatment_term_name: Interleukin-15; treatment_type: protein; duration: 72; duration_units: hour; treatment_term_id: UniProtKB:P29460; treatment_term_name: Interleukin-12 subunit beta; treatment_type: protein; duration: 72; duration_units: hour; treatment_term_id: UniProtKB:Q14116; treatment_term_name: Interleukin-18; treatment_type: protein; duration: 72; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS311PCG

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ATP5F1A

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS311PCG: RNA-seq on K562 cells treated with a CRISPR gRNA against ATP5A1. (ATP5A1-BGKcLV26-37)


ENCODE biosample ENCBS312BGW

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SEC23IP

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS312BGW: RNA-seq on K562 cells treated with a CRISPR gRNA against SAP30BP. (SAP30BP-BGKcLV33-30)


ENCODE biosample ENCBS312MQH

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SRA1

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS312MQH: RNA-seq on K562 cells treated with a CRISPR gRNA against SPATS2. (SPATS2-BGKcLV33-70)

characteristic: title


ENCODE biosample ENCBS314GPV

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

text: 58 year

characteristic: cell line

text: Homo sapiens A549 cell line treated with 1 uM ZK216348 (agonist) for 4 hours

characteristic: description

text: adult

characteristic: dev stage

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS314GPV

text: treatment_term_name: ZK216348; treatment_type: chemical; duration: 4; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS314RQJ

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 83 year

text: Homo sapiens female adult (83 years) middle frontal area 46 tissue

text: adult

characteristic: donor ID

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS314RQJ: human_brain_Rush ID_E8583444_BS184_ENC4_cDNA738


ENCODE biosample ENCBS315KVT

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

text: 62 year

text: Homo sapiens male adult (62 years) heart left ventricle tissue, preserved by flash-freezing

text: adult

text: viral->sarcoid (EF 15%, LVEDD 5.8, LVPWd 0.79)

characteristic: health state

text: Michael Snyder, Stanford

text: Homo sapiens

text: tissue

text: male

characteristic: sex

text: Shin Lin

characteristic: source

text: heart left ventricle

text: ENCODE biosample ENCBS315KVT: Homo sapiens heart left ventricle tissue


ENCODE biosample ENCBS315ZKM

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CPSF7

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS315ZKM: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CPSF7. (CPSF7-BGHcLV29-39)

characteristic: title


ENCODE biosample ENCBS317HDH

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 83 year

text: Homo sapiens male adult (83 years) middle frontal area 46 tissue

characteristic: description

text: adult

characteristic: dev stage

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: male

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS317HDH: human_brain_Rush ID_E8947111_BS186_ENC4_cDNA740


ENCODE biosample ENCBS317HMK

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens AIMP1

text: child

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: ATCC

text: ENCODE biosample ENCBS317HMK: RNA-seq on HepG2 cells treated with a CRISPR gRNA against AIMP1. (AIMP1-BGHcLV27-4)


ENCODE biosample ENCBS320KXQ

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission package

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SCAF8

text: child

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS320KXQ: RNA-seq on HepG2 cells treated with a CRISPR gRNA against SCAF8. (SCAF8-BGHcLV31-30)


ENCODE biosample ENCBS320ZIE

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: 15 year

characteristic: age

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS320ZIE: RNA-seq on HepG2 cells treated with a CRISPR gRNA against SCAF8. (SCAF8-BGHcLV31-29)


ENCODE biosample ENCBS321ZFD

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RPS28

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS321ZFD: RNA-seq on K562 cells treated with a CRISPR gRNA against CD2BP2. (CD2BP2-BGKcLV33-6)

characteristic: title


ENCODE biosample ENCBS322OXY

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with mild cognitive impairment; middle frontal area 46 tissue

text: adult

characteristic: dev stage

characteristic: donor ID

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS322OXY: human_brain_Rush ID_E8392249_BS212_ENC4_cDNA767


ENCODE biosample ENCBS322PWU

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission package

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with Alzheimer's disease; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: female

characteristic: sex

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS322PWU: human_brain_Rush ID_E7334238_BS161_ENC4_cDNA711


ENCODE biosample ENCBS323KDI

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: 53 year

characteristic: age

characteristic: cell line

text: Homo sapiens K562 cell line treated with 10 nM Chaetocin for 12 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS323KDI: RNA-seq on human cell line K562

text: treatment_term_name: Chaetocin; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS323XPY

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 22 year

text: activated B cell

characteristic: cell type

text: Homo sapiens male adult (22 years) activated B primary cell treated with 0.5 uM CpG ODN for 24 hours

characteristic: description

text: adult

text: Yijun Ruan, JAX

characteristic: lab

text: Homo sapiens

characteristic: organism

text: primary cell

text: male

text: AllCells

text: ENCODE biosample ENCBS323XPY

characteristic: title

text: treatment_term_name: CpG ODN; treatment_type: chemical; duration: 24; duration_units: hour;


ENCODE biosample ENCBS325UGX

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens PSMA1

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: ATCC

text: ENCODE biosample ENCBS325UGX: RNA-seq on HepG2 cells treated with a CRISPR gRNA against PSMA1. (PSMA1-BGHcLV25-51)


ENCODE biosample ENCBS326SBM

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: 53 year

characteristic: age

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ALDOA

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS326SBM: RNA-seq on K562 cells treated with a CRISPR gRNA against ALDOA. (ALDOA-BGKcLV26-24)


ENCODE biosample ENCBS327BWP

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 48 year

text: Homo sapiens OCI-LY7 cell line, subjected to a 2 hour pulse-chase

characteristic: description

text: adult

text: B cell lymphoma

text: Mats Ljungman, UMichigan

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: DSMZ

text: ENCODE biosample ENCBS327BWP


ENCODE biosample ENCBS327PNC

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with Cognitive impairment, Alzheimer's disease; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS327PNC: human_brain_Rush ID_E6735279_BS207_ENC4_cDNA762

characteristic: title


ENCODE biosample ENCBS328HQA

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CARS

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS328HQA: RNA-seq on K562 cells treated with a CRISPR gRNA against CARS. (CARS-BGKcLV26-57)


ENCODE biosample ENCBS328JBR

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 48 year

characteristic: age

characteristic: cell line

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens MED14 treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: Dr. Masato Kanemaki

characteristic: source

text: ENCODE biosample ENCBS328JBR

text: treatment_term_name: 5-Phenyl-1H-indole-3-acetic acid; treatment_type: chemical; duration: 6; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS328MIH

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SAP30BP

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS328MIH: RNA-seq on K562 cells treated with a CRISPR gRNA against RUVBL1. (RUVBL1-BGKcLV33-23)


ENCODE biosample ENCBS330HJH

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens DCPS

text: child

characteristic: dev stage

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS330HJH: RNA-seq on HepG2 cells treated with a CRISPR gRNA against DCPS. (DCPS-BGHcLV29-63)

characteristic: title


ENCODE biosample ENCBS332QIZ

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 15 year

characteristic: age

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RUVBL1

text: child

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: ATCC

text: ENCODE biosample ENCBS332QIZ: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RUVBL1. (RUVBL1-BGHcLV31-19)


ENCODE biosample ENCBS334DIV

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RBM14

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS334DIV: RNA-seq on K562 cells treated with a CRISPR gRNA against RBM14. (RBM14-BGKcLV30-5)


ENCODE biosample ENCBS334NVI

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with Alzheimer's disease; middle frontal area 46 tissue

characteristic: description

text: adult

text: Barbara Wold, Caltech

characteristic: lab

text: Homo sapiens

text: tissue

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS334NVI: human_brain_Rush ID_E9696602_BS191_ENC4_cDNA745


ENCODE biosample ENCBS336JAA

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CAST

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS336JAA: RNA-seq on K562 cells treated with a CRISPR gRNA against CAST. (CAST-BGKcLV26-60)

characteristic: title


ENCODE biosample ENCBS338LGZ

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: 53 year

characteristic: age

characteristic: cell line

text: Homo sapiens K562 cell line treated with 50 uM C646 for 48 hours, preserved by flash-freezing

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS338LGZ: RNA-seq on human cell line K562

text: treatment_term_name: C646; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS338UWS

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CAND1

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS338UWS: RNA-seq on K562 cells treated with a CRISPR gRNA against CAND1. (CAND1-BGKcLV26-52)


ENCODE biosample ENCBS339RWG

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 30 year

text: Homo sapiens WTC11 cell line, preserved by flash-freezing

characteristic: description

text: adult

characteristic: dev stage

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: Coriell

text: ENCODE biosample ENCBS339RWG: iPSC


ENCODE biosample ENCBS339UDB

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: 36 year

characteristic: age

text: MCF 10A

characteristic: cell line

text: Homo sapiens MCF 10A cell line, subjected to a 6 hour pulse-chase

text: adult

characteristic: donor ID

text: fibrocystic disease

text: Mats Ljungman, UMichigan

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS339UDB

characteristic: title


ENCODE biosample ENCBS344ACZ

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 72 year

text: Homo sapiens Caco-2 cell line

text: adult

text: colorectal adenocarcinoma

characteristic: health state

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: ATCC

text: ENCODE biosample ENCBS344ACZ


ENCODE biosample ENCBS344KXS

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RBM28

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS344KXS: RNA-seq on K562 cells treated with a CRISPR gRNA against RBM28. (RBM28-BGKcLV30-18)


ENCODE biosample ENCBS347UZX

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: endothelial cell of umbilical vein

characteristic: cell type

text: Homo sapiens male newborn endothelial of umbilical vein primary cell treated with 500 rad irradiation

characteristic: description

text: newborn

characteristic: dev stage

text: Mats Ljungman, UMichigan

characteristic: lab

text: Homo sapiens

text: primary cell

text: male

text: Lonza

text: ENCODE biosample ENCBS347UZX

text: treatment_term_name: irradiation; treatment_type: irradiation;

characteristic: treatments


ENCODE biosample ENCBS347VSX

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 53 year

characteristic: age

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SF3B2

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS347VSX: RNA-seq on K562 cells treated with a CRISPR gRNA against SEPT11. (SEPT11-BGKcLV33-46)

characteristic: title


ENCODE biosample ENCBS350CVC

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: Homo sapiens PC-9 cell line treated with 500 rad irradiation

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

characteristic: sample type

text: not collected

text: Sigma

text: ENCODE biosample ENCBS350CVC


ENCODE biosample ENCBS352YCX

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 86 year

text: Homo sapiens female adult (86 years) with mild cognitive impairment; middle frontal area 46 tissue

characteristic: description

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

characteristic: sex

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS352YCX: human_brain_Rush ID_E1329219_BS173_ENC4_cDNA727


ENCODE biosample ENCBS353AGW

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 43 year

characteristic: age

text: T-cell

characteristic: cell type

text: Homo sapiens male adult (43 years) T-cell primary cell

text: adult

characteristic: dev stage

text: John Stamatoyannopoulos, UW

characteristic: lab

text: Homo sapiens

text: primary cell

text: male

text: StemExpress

text: ENCODE biosample ENCBS353AGW


ENCODE biosample ENCBS355KGS

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

text: live

text: Generic

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CNDP2

text: child

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS355KGS: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CNDP2. (CNDP2-BGHcLV29-27)

characteristic: title


ENCODE biosample ENCBS356JLC

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: endothelial cell of umbilical vein

text: Homo sapiens male newborn endothelial of umbilical vein primary cell, subjected to a 2 hour pulse-chase

characteristic: description

text: newborn

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: primary cell

characteristic: sample type

text: male

text: Lonza

text: ENCODE biosample ENCBS356JLC


ENCODE biosample ENCBS358QAI

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ALKBH1

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS358QAI: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ALKBH1. (ALKBH1-BGHcLV24-10)


ENCODE biosample ENCBS359SKL

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RRP8

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS359SKL: RNA-seq on K562 cells treated with a CRISPR gRNA against RPS28. (RPS28-BGKcLV33-14)


ENCODE biosample ENCBS360EBB

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line treated with 10 nM Chaetocin for 48 hours, preserved by flash-freezing

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS360EBB: RNA-seq on human cell line K562

characteristic: title

text: treatment_term_name: Chaetocin; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS360KJV

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 58 year

text: Homo sapiens A549 cell line treated with 1 uM AZD9567 (agonist) for 4 hours

characteristic: description

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: ATCC

text: ENCODE biosample ENCBS360KJV

text: treatment_term_name: AZD9567; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS364ERK

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: 48 year

characteristic: age

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens RAD21 treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: Dr. Masato Kanemaki

characteristic: source

text: ENCODE biosample ENCBS364ERK

text: treatment_term_name: 5-Phenyl-1H-indole-3-acetic acid; treatment_type: chemical; duration: 6; duration_units: hour;


ENCODE biosample ENCBS367BPG

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ACO2

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS367BPG: RNA-seq on K562 cells treated with a CRISPR gRNA against ACO2. (ACO2-BGKcLV26-3)


ENCODE biosample ENCBS368BJM

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with mild cognitive impairment; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS368BJM: human_brain_Rush ID_E7763031_BS210_ENC4_cDNA765

characteristic: title


ENCODE biosample ENCBS368CDS

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ARHGEF1

characteristic: description

text: child

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: ATCC

text: ENCODE biosample ENCBS368CDS: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ARHGEF1. (ARHGEF1-BGHcLV27-14)


ENCODE biosample ENCBS369CJT

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS369CJT: Control CRISPR gRNA against no target in K562 cells followed by RNA-seq. (NT-BGKcLV26-1)


ENCODE biosample ENCBS369YWA

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 48 year

characteristic: cell line

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens CDK7 treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

characteristic: dev stage

characteristic: donor ID

text: colorectal carcinoma

text: Erez Aiden, Baylor

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS369YWA

characteristic: treatments


ENCODE biosample ENCBS370DEJ

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line treated with 7.5 nM Panobinostat for 12 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS370DEJ: RNA-seq on human cell line K562

characteristic: title

text: treatment_term_name: Panobinostat; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS372KDQ

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 85 year

text: Homo sapiens female adult (85 years) with Alzheimer's disease; middle frontal area 46 tissue

characteristic: description

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS372KDQ: human_brain_Rush ID_E1097236_BS118_ENC4_cDNA680


ENCODE biosample ENCBS372TCT

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 58 year

characteristic: age

characteristic: cell line

text: Homo sapiens A549 cell line treated with 1 uM ZK216348 (agonist) for 4 hours

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS372TCT

text: treatment_term_name: ZK216348; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS373FPT

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ADK

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS373FPT: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ADK. (ADK-BGHcLV25-16)


ENCODE biosample ENCBS373KON

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ADAT3

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS373KON: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ADAT3. (ADAT3-BGHcLV24-7)

characteristic: title


ENCODE biosample ENCBS374GUN

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RBM8A

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS374GUN: RNA-seq on K562 cells treated with a CRISPR gRNA against RBM8A. (RBM8A-BGKcLV30-23)


ENCODE biosample ENCBS375PHK

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: 87 year

characteristic: age

text: Homo sapiens female adult (87 years) with mild cognitive impairment; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

characteristic: sex

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS375PHK: human_brain_Rush ID_E6422513_BS206_ENC4_cDNA761


ENCODE biosample ENCBS376DUX

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens BZW2

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS376DUX: RNA-seq on HepG2 cells treated with a CRISPR gRNA against BZW2. (BZW2-BGHcLV27-30)


ENCODE biosample ENCBS377PCM

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 90 or above year

text: Homo sapiens female adult (90 or above years) middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

text: female

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS377PCM: human_brain_Rush ID_2327042_BS92_ENC4_cDNA669

characteristic: title


ENCODE biosample ENCBS379TMH

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 36 year

text: Homo sapiens HL-60 cell line treated with 10 uM phorbol 13-acetate 12-myristate for 120 hours, 10 ng/mL interleukin-13 for 24 hours, 10 ng/mL interleukin-4 for 24 hours

characteristic: description

text: adult

text: acute promyelocytic leukemia

text: Ali Mortazavi, UCI

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS379TMH: HL-60 derived M2A macrophages (24hr)

text: treatment_term_id: CHEBI:37537; treatment_term_name: phorbol 13-acetate 12-myristate; treatment_type: chemical; duration: 120; duration_units: hour; treatment_term_id: UniProtKB:P35225; treatment_term_name: interleukin-13; treatment_type: protein; duration: 24; duration_units: hour; treatment_term_id: UniProtKB:P05112; treatment_term_name: interleukin-4; treatment_type: protein; duration: 24; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS380AKB

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

text: 36 year

characteristic: age

characteristic: cell line

text: Homo sapiens HL-60 cell line treated with 10 uM phorbol 13-acetate 12-myristate for 120 hours, 100 ng/mL lipopolysaccharide for 12 hours, 100 ng/mL interferon gamma for 12 hours

text: adult

characteristic: dev stage

text: acute promyelocytic leukemia

text: Ali Mortazavi, UCI

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS380AKB: HL-60 derived M1 macrophages (12hr)

text: treatment_term_id: CHEBI:37537; treatment_term_name: phorbol 13-acetate 12-myristate; treatment_type: chemical; duration: 120; duration_units: hour; treatment_term_id: CHEBI:16412; treatment_term_name: lipopolysaccharide; treatment_type: chemical; duration: 12; duration_units: hour; treatment_term_id: UniProtKB:P01579; treatment_term_name: interferon gamma; treatment_type: protein; duration: 12; duration_units: hour;


ENCODE biosample ENCBS380OHA

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

text: 58 year

text: Homo sapiens A549 cell line treated with 1 uM DMSO (agonist) for 4 hours

text: adult

characteristic: donor ID

text: Tim Reddy, Duke

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS380OHA

text: treatment_term_id: CHEBI:28262; treatment_term_name: DMSO; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS383JCE

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: SRA accession

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens SMARCA5

text: adult

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS383JCE

characteristic: title


ENCODE biosample ENCBS383JOT

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CNDP2

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS383JOT: RNA-seq on K562 cells treated with a CRISPR gRNA against CNDP2. (CNDP2-BGKcLV28-28)


ENCODE biosample ENCBS383XHL

text: ENCODE

text: live

text: Generic

text: 53 year

characteristic: age

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RPUSD2

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS383XHL: RNA-seq on K562 cells treated with a CRISPR gRNA against SKIV2L2. (SKIV2L2-BGKcLV33-9)


ENCODE biosample ENCBS384SFY

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RBM26

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS384SFY: RNA-seq on K562 cells treated with a CRISPR gRNA against RBM26. (RBM26-BGKcLV30-14)


ENCODE biosample ENCBS384UVR

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CAPRIN1

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS384UVR: RNA-seq on K562 cells treated with a CRISPR gRNA against CAPRIN1. (CAPRIN1-BGKcLV26-53)


ENCODE biosample ENCBS385NOB

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SMG9

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS385NOB: RNA-seq on K562 cells treated with a CRISPR gRNA against SMG7. (SMG7-BGKcLV33-57)

characteristic: title


ENCODE biosample ENCBS387BKP

text: ENCODE

text: live

text: Generic

text: 87 year

characteristic: age

text: Homo sapiens female adult (87 years) with mild cognitive impairment; middle frontal area 46 tissue

text: adult

characteristic: dev stage

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: female

characteristic: sex

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS387BKP: human_brain_Rush ID_E7584572_BS209_ENC4_cDNA764


ENCODE biosample ENCBS387CRZ

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RRP8

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS387CRZ: RNA-seq on K562 cells treated with a CRISPR gRNA against RPS28. (RPS28-BGKcLV33-13)


ENCODE biosample ENCBS390UFY

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: SRA accession

text: 58 year

text: Homo sapiens A549 cell line treated with 1 uM AZD2906 (agonist) for 4 hours

text: adult

text: Tim Reddy, Duke

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS390UFY

text: treatment_term_name: AZD2906; treatment_type: chemical; duration: 4; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS390WRH

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SPATS2L

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS390WRH: RNA-seq on K562 cells treated with a CRISPR gRNA against SPAG9. (SPAG9-BGKcLV33-68)

characteristic: title


ENCODE biosample ENCBS391LZS

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

text: 19 year

text: mammary epithelial cell

characteristic: cell type

text: Homo sapiens female adult (19 years) mammary epithelial primary cell treated with 500 rad irradiation

text: adult

characteristic: dev stage

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: primary cell

characteristic: sample type

text: female

characteristic: sex

text: Lonza

text: ENCODE biosample ENCBS391LZS

text: treatment_term_name: irradiation; treatment_type: irradiation;


ENCODE biosample ENCBS391QCN

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: SRA accession

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SEC62

text: child

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS391QCN: RNA-seq on HepG2 cells treated with a CRISPR gRNA against SEC62. (SEC62-BGHcLV31-35)


ENCODE biosample ENCBS394BIN

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RIOK1

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS394BIN: RNA-seq on K562 cells treated with a CRISPR gRNA against RIOK1. (RIOK1-BGKcLV30-33)


ENCODE biosample ENCBS394PBH

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CSNK1E

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS394PBH: RNA-seq on K562 cells treated with a CRISPR gRNA against CSNK1E. (CSNK1E-BGKcLV28-46)

characteristic: title


ENCODE biosample ENCBS395DLA

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

text: 89 year

text: Homo sapiens female adult (89 years) with Alzheimer's disease; middle frontal area 46 tissue

text: adult

characteristic: dev stage

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: female

characteristic: sex

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS395DLA: human_brain_Rush ID_E8949399_BS187_ENC4_cDNA741


ENCODE biosample ENCBS395IEJ

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: SRA accession

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ACTN4

text: child

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS395IEJ: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ACTN4. (ACTN4-BGHcLV25-5)


ENCODE biosample ENCBS395PUX

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 83 year

characteristic: age

text: Homo sapiens male adult (83 years) middle frontal area 46 tissue

characteristic: description

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

text: male

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS395PUX: human_brain_Rush ID_E2351217_BS143_ENC4_cDNA693


ENCODE biosample ENCBS396XJP

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: John Lis, Cornell

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS396XJP

characteristic: title


ENCODE biosample ENCBS398SEX

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ACTN4

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS398SEX: RNA-seq on K562 cells treated with a CRISPR gRNA against ACTN4. (ACTN4-BGKcLV26-5)


ENCODE biosample ENCBS398SGO

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens APTX

text: child

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS398SGO: RNA-seq on HepG2 cells treated with a CRISPR gRNA against APTX. (APTX-BGHcLV24-12)


ENCODE biosample ENCBS402MPB

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line

characteristic: description

text: child

text: hepatocellular carcinoma

text: Ali Mortazavi, UCI

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS402MPB: HepG2


ENCODE biosample ENCBS404ERD

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission package

text: 15 year

text: Homo sapiens A673 cell line, subjected to a 2 hour pulse-chase

text: child

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS404ERD


ENCODE biosample ENCBS408PRS

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line treated with 7.5 nM Vorinostat for 4 hours, preserved by flash-freezing

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS408PRS: RNA-seq on human cell line K562

characteristic: title

text: treatment_term_name: Vorinostat; treatment_type: chemical; duration: 4; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS409RMM

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CDK9

text: child

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS409RMM: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CDK9. (CDK9-BGHcLV29-14)


ENCODE biosample ENCBS410LGD

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 58 year

characteristic: age

text: Homo sapiens A549 cell line treated with 1 uM CpdA (agonist) for 4 hours

characteristic: description

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS410LGD

text: treatment_term_name: CpdA; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS411JUI

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 79 year

text: Homo sapiens female adult (79 years) middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS411JUI: human_brain_Rush ID_5194210_BS19_ENC4_cDNA654


ENCODE biosample ENCBS411JWD

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 1% DMSO for 4 hours, preserved by flash-freezing

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS411JWD: RNA-seq on human cell line K562

characteristic: title

text: treatment_term_name: DMSO; treatment_type: chemical; duration: 4; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS413SQG

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ADAT1

characteristic: description

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS413SQG: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ADAT1. (ADAT1-BGHcLV25-11)


ENCODE biosample ENCBS417HWB

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RPUSD2

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS417HWB: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RPUSD2. (RPUSD2-BGHcLV31-13)


ENCODE biosample ENCBS418FLR

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: SRA accession

text: 36 year

text: MCF 10A

characteristic: cell line

text: Homo sapiens MCF 10A cell line treated with 500 rad irradiation

text: adult

characteristic: dev stage

characteristic: donor ID

text: fibrocystic disease

characteristic: health state

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS418FLR

text: treatment_term_name: irradiation; treatment_type: irradiation;


ENCODE biosample ENCBS418TNU

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CLNS1A

characteristic: description

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS418TNU: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CLNS1A. (CLNS1A-BGHcLV29-21)

characteristic: title